Evaluation of selective inhibitors of 11ß-HSD1 for the treatment of hypertension.
Bioorg Med Chem Lett
; 23(12): 3650-3, 2013 Jun 15.
Article
en En
| MEDLINE
| ID: mdl-23659858
ABSTRACT
In an effort to understand the origin of blood-pressure lowering effects observed in recent clinical trials with 11ß-HSD1 inhibitors, we examined a set of 11ß-HSD1 inhibitors in a series of relevant in vitro and in vivo assays. Select 11ß-HSD1 inhibitors reduced blood pressure in our preclinical models but most or all of the blood pressure lowering may be mediated by a 11ß-HSD1 independent pathway.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Triazoles
/
11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 1
/
Inhibidores Enzimáticos
/
Hipertensión
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Bioorg Med Chem Lett
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos